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Zalpha domains are a subfamily of the winged helix-turn-helix domains sharing the unique ability to recognize CpG repeats in
the left-handed Z-DNA conformation. In vertebrates, domains of this family are found exclusively in proteins that detect foreign
nucleic acids and activate components of the antiviral interferon response. Moreover, poxviruses encode the Zalpha domain-
containing protein E3L, a well-studied and potent inhibitor of interferon response. Here we describe a herpesvirus Zalpha-do-
main-containing protein (ORF112) from cyprinid herpesvirus 3. We demonstrate that ORF112 also binds CpG repeats in the
left-handed conformation, andmoreover, its structure at 1.75 Å reveals the Zalpha fold found in ADAR1, DAI, PKZ, and E3L.
Unlike other Zalpha domains, however, ORF112 forms a dimer through a unique domain-swapping mechanism. Thus, ORF112
may be considered a newmember of the Z-domain family having DNA binding properties similar to those of the poxvirus E3L
inhibitor of interferon response.
Zalpha domains represent a subfamily of winged helix-turn-helix (wHTH) domains with the unique property of specific
binding to purine/pyrimidine repeats in the left-handed helical
conformation known as Z-DNA (1). Typically, Zalpha domains
are 66 amino acids long (Pfam 02295) adopting a fold consisting
of 3 alpha helices and 3 beta strands arranged in 112323
topology. Helix 3 and the loop connecting the 2 and 3 strands,
called the wing, have been found to interact with DNA in the
cocrystal structure of the ADAR1 Zalpha domain with a short
(CG)3 oligonucleotide (2). The surprising feature of the Zalpha-
DNA complex is that the DNA adopts the left-handed helical con-
formation, rather than the naturally occurring right-handed B
form (3). It is still an open question whether Zalpha actively in-
duces the conformational transition or selectively binds the left-
handed form, which is in equilibrium with the right-handed con-
formation.
Interestingly, a very similar behavior was found to occur
with (CG)3 oligonucleotides in double-strand RNA (dsRNA)
(4), allowing Zalpha to bind both dsDNA and dsRNA of the
same sequence. The ADAR1 Zalpha DNA cocrystal structure
and several structures of Zalpha domains from other proteins
(5–7) have established key features of the domain necessary for
binding DNA/RNA: a tyrosine, an asparagine, and a trypto-
phan (Tyr177, Asn173, and Trp195 in ADAR1 Zalpha) form a
unique and conserved structural motif in all known structures
and sequences of Zalpha domains (1). A mutation of any of
these three residues results in the loss of specific DNA binding,
and this triplet, along with hydrophobic residues involved in
the folding of the protein, defines a characteristic signature of
the Zalpha domain that distinguishes it from the rest of the
wHTH DNA binding domains (8).
Significantly, members of this domain subfamily have been
found in the vertebrate proteins ADAR1, DAI, and PKZ (3, 5, 9),
all of which are involved in the antiviral interferon response path-
way. Functionally, DAI and Z-DNA-dependent protein kinase
(PKZ) are components of the machinery responsible for the rec-
ognition of foreign nucleic acids in the cytoplasm and have been
implicated in the initiation of a cascade that blocks cellular trans-
lation and leads to the production of type I interferons. Similarly,
a Zalpha domain is also found in a virally encoded protein (E3L)
that acts as an inhibitor of the interferon response (10). E3L is a
key protein in the pathogenesis of poxviruses. Thus, strains with
nonfunctional E3L dramatically lose their proliferation potential.
The E3L protein consists of two domains, a C-terminal dsRNA-
binding domain (dsRBD) and anN-terminal Zalpha domain, and
both domains have been shown to be required to fully block host
responses (11). Surprisingly, however, no other virus family has
been found to encode a Zalpha-containing protein.
Themost recently discoveredZalpha-containing protein, PKZ,
is uniquely found in bony-fish species of the orders Cypriniformes
and Salmoniformes, including the laboratory model zebrafish
(Danio rerio) and common species, such as Atlantic salmon
(Salmo salar) and goldfish (Carassius auratus). This protein bears
a kinase domain strongly related to protein kinase R (PKR) and
two Zalpha domains (9). The key difference between the two pro-
teins is that PKZ contains two Z-DNAbinding domains instead of
the dsRNA binding domains (dsRBDs) found in PKR. The latter
dsRBDs are responsible for sensing viral dsRNA in the cytoplasm,
leading to the self-activation of PKR and the phosphorylation of
eIF2 and eventually resulting in the shutdown of cellular trans-
lation. This and additional functions attributed to PKR render this
protein the central node of innate responses in vertebrates. PKZ
blocks cellular translation in a similar manner but in response to
DNA CG repeats (12). Thus, in these fish species, a different and
unstudied nucleic acid sequence/structure appears to be active as a
pathogen-associated molecular pattern (PAMP).
Received 9 November 2012 Accepted 22 January 2013
Published ahead of print 30 January 2013
Address correspondence to Alekos Athanasiadis, alekos@igc.gulbenkian.pt.
A.R.T. and K.K. contributed equally to this work.
Copyright © 2013, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JVI.03116-12
The authors have paid a fee to allow immediate free access to this article.
3998 jvi.asm.org Journal of Virology p. 3998–4004 April 2013 Volume 87 Number 7
 o
n
 N
ovem
ber 10, 2015 by INSTITUTO
 G
ULBENKIAN DE CIENCI
http://jvi.asm.org/
D
ow
nloaded from
 
Herpesviruses of the family Alloherpesviridae are important
pathogens of fish and amphibians species (13). Despite their sim-
ilar morphology, members of the family Alloherpesviridae have
gene content distinct from that of members of the Herpesviridae,
which infect mammals, birds, and reptiles. Significantly, Alloher-
pesviridae genomes contain at least three genes encoding proteins
that are characteristic of poxviruses (14). Horizontal gene transfer
or a common ancestor has been proposed as a source of the gene
overlap between poxviruses and Alloherpesviridae. Cyprinid her-
pesvirus 3 (CyHV3) is a typical member ofAlloherpesviridae and a
major pathogen of common carp and koi (15). Infection by
CyHV3 has become a significant threat to aquaculture as well as
the wild population of carp, as its mortality rate can be as high as
95%, threatening fish farms worldwide. Recently the genome of
CyHV3 was sequenced, providing key information for under-
standing the biology of the infection and particularly host-patho-
gen interactions.
Here we show that cyprinid herpesvirus 3 open reading frame
112 encodes a protein that, in vitro, has a structural and functional
Zalpha domain, similar to both the poxviral interferon response
inhibitor E3L and the PKZ protein of the fish species that CyHV3
infects. Our findings suggest thatAlloherpesviridae and poxviruses
may use a similar mechanism to subvert the interferon response,
and this allows us to assign a potentially crucial role in virus patho-
genesis to Alloherpesviridae ORF112 function.
MATERIALS AND METHODS
Cloning and expression. Sequences encompassing M221-A278, S219-
A278, and N216-A278 of ORF112 (BAF48926.1) were amplified from
CyHV-3 genomic DNA (kindly provided by the Friedrich-Loeffler Insti-
tute) and cloned in a pET28a vector as a fusion with a 6His tag at the
NheI-XhoI restriction sites. Protein expressionwas induced in Escherichia
coli BL21(DE3) cells with the addition of 0.4 mM IPTG (isopropyl--D-
thiogalactopyranoside) for 3 h. Cell pellets from1-liter cultures were lysed
with Bugbuster (Novagen) in the presence of 1mMphenylmethylsulfonyl
fluoride (PMSF) and Benzonase (Novagen) for 2 h at 4°C. The proteins
were loaded on aHiTrap nickel-nitrilotriacetic acid (Ni-NTA) column on
an Äkta purifier system and eluted using a gradient between 20 mM and
300 mM imidazole. The first construct did not result in any detectable
protein production. The eluted protein from the other two constructs was
dialyzed against 0.5 thrombin buffer (10 mM Tris [pH 8.4], 75 mM
NaCl, 1.25 mM CaCl2) and incubated with thrombin overnight at 4°C.
The cleaved proteins were directly applied to a MonoS column and then
eluted with a 75-to-600 mM NaCl gradient. Selected fractions were con-
centrated and buffer exchanged to a final concentration of 7.5mg/ml in 20
mM Tris (pH 7.5), 50 mM KCl or 10 mMHEPES, 50 mMNaCl (pH 7.4)
for use in crystallization and biochemical characterization.
Protein crystallization. The purified protein was used for crystalliza-
tion screens (Crystal Screen I-II from Hampton Research and the Joint
Center for Structural Genomics fromMolecular Dimensions) in complex
with T(CG)3 duplex oligonucleotides, and crystals were obtained under
several conditions. However, in all cases the crystals were also reproduc-
ible in controls in the absence of nucleic acids, suggesting that only the
protein component had been crystallized. Highest-quality rod-shaped
crystals (0.2 by 0.05 by 0.05 m) were obtained using a reservoir con-
taining 0.2 M NaCl, 0.1 M cacodylate (pH 6.5), and 2 M ammonium
sulfate. Well-shaped crystals were subsequently frozen at 100 K in the
presence of Paratone N or 20% glycerol as a cryoprotectant.
Data collection and structure determination. Flash-frozen crystals at
100 K were exposed to X rays at the ID23-1 beam line of ESRF/Grenoble
using X rays of 0.97 Å in wavelength. The best crystal diffracted up to 1.76
Å. Data processing was performed using the XDS software package (16).
The ORF112 Zalpha crystals belong to the P212121 space group with the
following parameters: a 51.7Å, b 54.6Å, c 86.6Å, and
90.00°. Phasing performed using molecular replacement with ADAR1
Zalpha (PDB code 1QBJ) as the starting model was successful when a
C-terminally truncated model only was used, leading to a solution with
four monomers per asymmetric unit. The structure was refined from the
startingmodel using Phenix (17) and iterative rebuilding using Coot (18).
The resulting electron density clearly showed the C terminus of the pro-
tein leading to a neighboring monomer, suggesting domain swapping of
the last beta-strand and resulting in an arrangement of two dimers per
asymmetric unit. The final refined model has an R/Rfree ratio of 20.1/24.7
and comprises 248 protein residues and 213 solvent molecules, among
which are 9 sulfate ions (see Table 1 for statistics). The backbone of P217-
A278, S215-P277,H212-A278, and S219-A278 fromchainsA, B,C, andD,
respectively, was visible in the electron density map. Some side chains of
solvent-exposed amino acids (S215B, N216B, H212C, M213C, R266C,
R266D, and Q270D) had no visible electron density, while the side chain
of H188C shows two alternative conformations which were both mod-
eled. The nine sulfate ions could be located in the structure in similar
positions in each the four monomers.
DNA binding assays. The ability of the purified protein to bind DNA
was evaluated by gel mobility shift analysis using a T(CG)3 duplex oligo-
nucleotide (Integrated DNA Technologies). Mixtures of protein with 50
M DNA at ratios of 1/1 to 4/1 were incubated at 37°C for 20 min and
then subjected to electrophoresis on nondenaturing polyacrylamide gels
and stained with SYBR followed by Coomassie blue. A distinct band cor-
responding to the protein-DNA complex was clearly visible. Complete
conversion toZ-DNAcould be observed at protein/DNA ratios of 2:1. The
conformation of the oligonucleotides in the complex was evaluated using
circular dichroism (CD) spectroscopy on a Jasco J-815 CD system in a
0.1-mm cuvette. A clear inversion of the trace, characteristic of the Z-
DNA helix, was observed at a wavelength of 255 nm (see Fig. 2C).
Size exclusion chromatography characterization. We used size ex-
clusion chromatography to characterize the oligomerization state of the
protein in solution. An S75 prepacked column (GEHealthcare) was equil-
ibrated with 50 mM Tris (pH 7.5) and 100 mM KCl and calibrated using
protein standards (molecular mass, 6,500 to 66,000 Da; Sigma-Aldrich).
ORF112 Zalpha protein (1 mg) in a volume of 200 l was loaded on the
column, and the elution profile was compared with that of the standards
showing a single peak corresponding to a molecular mass of 7.7 kDa, in
TABLE 1 Data collection and refinement statistics
Parameter Result
Data set Cr2_19w1
Beam line ID23-1
Resolution 46.18–1.75 Å
Space group P212121
Cell parameters a 51.7 Å, b 54.6 Å, c 86.6 Å,    
  90.0000°
Wavelength 0.97 Å
Rmerge (%) 3.6
I/I 13.1
Completeness (%) 94.8
Unique reflections 23721
Multiplicity 4.2
Wilson B 31.1
Refinement
Resolution 46.18–1.76 Å
Reflections 21,681
R/Rfree (%) 20.1/24.7
R/Rfree (%), outer cell 32.1/41.8
RMS bond 0.003
RMS angles 0.677
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good agreement with the predicted molecular mass for the monomer. A
similar procedure using the buffer used for crystallization revealed a novel
peak at the expected molecular mass for the dimer. The transition from
monomer to dimer was found to be induced by ammonium sulfate at
concentrations of 50 and 200 mM.
Protein structure accession numbers. The Zalpha domain crystal
structure determined here has been deposited in the RCSB database
(RCSB code RCSB075715; PDB code 4HOB).
RESULTS
Aputative Z-DNAbinding domain containing protein from cy-
prinid herpesviruses. Using sequence homology searches for
new members of the Z-domain family, we found a gene
(orf112) encoding a Z-domain-containing hypothetical pro-
tein (BAF48926.1) in the cyprinid herpesvirus 3 genome se-
quence (15). The gene, as annotated, encodes a 278-amino-
acid protein with the Z-domain signature located at its C
terminus (Fig. 1A), and its expression as cDNA has been con-
firmed (19). No recognizable homology could be detected for
the N-terminal part of the protein. Thus, unlike the poxviral
E3L protein, ORF112 does not contain an obvious dsRNA
binding domain. A shorter version of a 92-amino-acid protein,
encompassing mostly the Zalpha domain and starting from an
internal methionine (M187) residue, is possible.
The Zalpha domain of ORF112 shows highest identity
(Fig. 1B) with the Zalpha domain of PKZ from Gobiocypris rarus
(20) andDanio rerio (9), suggesting a functional and/or evolution-
ary relationship between PKZ and ORF112. ORF112 Zalpha con-
serves all residues known to be critical for interaction with DNA,
as defined by the prototypic ADAR1 Zalpha. Thus, residues
Tyr257, Asn253, and Trp274 correspond to Tyr177, Asn173, and
Trp195 of ADAR1 and are highly conserved among knownZalpha
domains. Similarly, the pattern of hydrophobic core residues im-
portant for folding of the wHTH domain is also conserved in
ORF112. The fact that no viral Zalpha domains have previously
been described outside the poxvirus family combined with the
relevance of Zalpha domains in viral pathogenicity prompted us
to clone and express the protein for further biochemical and struc-
tural characterization.
Cloning, protein expression and biochemical characteriza-
tion. Expression of the full-length ORF112, as annotated, in a
bacterial expression systemwas unsuccessful, resulting in a largely
insoluble protein (data not shown). However, we successfully ex-
pressed two ORF112 Zalpha constructs differing in length and
covering the regions from Ser219 to Ala278 and from Asn216 to
Ala278 as fusions with a cleavable His tag. Both constructs were
expressed as soluble proteins, but the shorter version was a tem-
perature-sensitive protein which, upon short incubation at 37°C,
formed protein aggregates and precipitated (data not shown). The
longer-form S216-A278 ORF112 Zalpha protein was purified to
homogeneity using affinity and ion-exchange chromatography
and was used for further biochemical characterization. Gel-mo-
bility shift assays with the purified protein against a T(CG)3 du-
plex oligonucleotide showed a robust band shift (Fig. 2A) similar
to that observed with Zalpha ADAR1, confirming the ability of
ORF112 Zalpha to interact with CpG repeats. In contrast, no spe-
cific complex was observed when ORF112 Zalpha1 was incubated
with sequences with a low propensity for forming Z-DNA
(Fig. 2B). We obtained similar results using a protein starting at
positionM187 (not shown) and likely representing the full-length
product of the gene. We concluded that the bound DNA is in the
left-handed conformation, as circular dichroism revealed the
characteristic Z-DNA inversion at 255 nm (Fig. 2C).
FIG 1 Identification of ORF112 of cyprinid herpesvirus 3 as a Zalpha domain-containing protein. (A) The annotated predicted protein is 278 amino acids (aa)
long, with a highly repetitive N terminus (BAF48926.1). An alternative, more likely product starts at position 186 and corresponds to slightly more than the
Zalpha domain (shading). The starting residues of the described Zalpha constructs are highlighted (dark shading). (B) Alignment of Zalpha ORF112 sequences
(CyHV3) with PKZ Zalpha1, E3L, and ADAR1 Zalpha domains. SS, Salmo salar; CA, Carassius auratus; CI, Ctenopharyngodon idella; DR, Danio rerio; GR,
Gobiocypris rarus; VV, vaccinia virus. The vertical bars over the sequence indicate the degree of conservation. The three key DNA-interacting residues in ADAR1
Zalpha are indicated with arrows, along with the residue numbering of ORF112 (corresponding to Asn174, Tyr177, and Trp195 in hADAR1).
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FIG 2 Zalpha ORF112 binds CpG repeats. (A) Zalpha ORF112 forms a complex with a T(CG)3 oligonucleotide, as demonstrated by electrophoresis on a native
polyacrylamide gel stained for nucleic acids with SYBR (left) and for proteins with Coomassie blue (right). Themolar ratio of protein to DNA is indicated above
the lanes. A gelmobility shift of the same oligonucleotide with ADAR1Zalpha at a protein/DNA ratio 2/1 is also shown (lane 2). (B)No specific bands are formed
between Zalpha ORF112 and a control duplex oligonucleotide AGC(TA)3GCT, as seen once again with SYBR staining (top) and Coomassie blue stain (bottom)
at molar ratios similar to those use for panel A. (C) Circular dichroism spectra of mixtures of ORF112 Zalpha with T(CG)3 DNA at ratios of 1/1, 2/1, and 4/1. A
characteristic inversion is observed at 255 nm compared to the B-DNA control (red line) indicating Z-DNA formation. (D) Gel retardation of a T(CG)3
oligonucleotide in the presence of ORF112 Zalpha (lanes 2 and 3) and PKZ Zalpha1 domains (lanes 4, 5, and 6) and in the presence of both domains (1:1 protein
ratios) (lanes 7, 8, and 9); lane 1 is the DNA-only control. Protein/DNA ratios in lanes 7, 8, and 9 reflect the total protein mixture-to-DNA ratio. Protein/DNA
ratios are given above the lanes. As in panels A and B, the same gel was stainedwith SYBR stain (top) andCoomassie stain (bottom) to visualizeDNA and protein,
respectively. (E, panel 1) Size exclusion chromatography on a Superdex 75 column in the absence of sulfate ions reveals a single peak corresponding to the
monomeric protein. (E, panel 2) Size exclusion chromatography in the presence of 50 mM ammonium sulfate (AS) revealed peaks corresponding to both
monomer and dimer oligomeric species. (F, panel 1) Gel retardation experiments with the T(CG)3 duplex oligonucleotide and the gel filtration fractions
representing the dimer (ratio 1/1) (Dim. lane 1) andmonomer (protein/DNA ratios, 1/1 and 2/1) (Mon. lanes 1 and 2) states ofORF112Zalpha. LaneC, no-DNA
control. AS, ammonium sulfate. (F, panel 2) Denaturing SDS-PAGE of gel filtration peak fractions P1 (monomer), P2 (dimer), and P3 (unknown) reveals that
all peaks have similar molecular weights.
Structure of the Zalpha Domain from CyHV3
April 2013 Volume 87 Number 7 jvi.asm.org 4001
 o
n
 N
ovem
ber 10, 2015 by INSTITUTO
 G
ULBENKIAN DE CIENCI
http://jvi.asm.org/
D
ow
nloaded from
 
To investigate a potential role for ORF112 as an inhibitor of
PKZ, we studied the ability of the ORF112 domain to compete for
DNA binding with the Zalpha domains of the zebrafish PKZ
(drPKZ). The two Zalpha domains (Za1 and Za2) of drPKZ were
expressed and purified to homogeneity, and Za1 was shown to be
a strong binder of CpG DNA (9, 21; our unpublished results). In
competition experiments comparing the binding of equimolar
amounts of ORF112 Zalpha and PKZ Zalpha1 to the T(CG)3 oli-
gonucleotide, the complex of ORF112 Zalpha/DNAwas preferen-
tially formed (Fig. 2D). Thus, ORF112 Zalpha is an efficient com-
petitive inhibitor with PKZ Zalpha for DNA binding under the
conditions we tested.
Having confirmed the ability of ORF112 to interact in vitro
with nucleic acids in the left-handed Z-DNA conformation, we
proceeded to its structural analysis by protein crystallography.
The crystal structure of the ORF112 Zalpha domain. Al-
though crystals of the protein alone were readily obtained, cocrys-
tallization of ORF112 Zalpha with DNA oligonucleotides failed to
produce crystals of the protein-DNA complex. The structure of
Zalpha ORF112 was determined at a resolution of 1.75 Å by mo-
lecular replacement using a truncated Zalpha ADAR1 (PDB code
1QBJ) as starting model. The asymmetric unit of the crystals is
composed of four Zalpha ORF112 monomers organized in two
nonidentical dimers (Fig. 3A). The two dimers differ in their sol-
vent structure and the angle formed between the two monomers.
Eachmonomer adopts a fold characteristic of the wHTHdomains
and shows a high degree of structural similarity with the proto-
typic ADAR1 Zalpha domain (Fig. 3B). Superposition of each of
the four monomers up to residue Lys185 with ADAR1 Zalpha
(PDB code 1QBJA) results in alignments with root mean square
difference (RMSDs) of 0.511, 0.570, 0.491 and 0.693 for mono-
mers A, B, C, and D, respectively. Despite the clear similarity in
folding between the monomers of ORF112 Zalpha and Zalpha
ADAR1, dimer formation between Zalpha domains has never
been observed before. Interestingly, the formation of dimers is
mediated by a C-terminal sequence exchange (“domain swap-
ping”). Thus, the two monomers reciprocally exchange their last
10 amino acids (a sequence which normally forms the wing) and
3, the last -strand of the domain (Fig. 3A). In contrast, the
crystal structures of ADAR1, DAI, and E3L Zalpha domains reveal
an entirely monomeric structure, despite the fact that two mono-
mers are typically bound to a single binding site, one on eachDNA
strand. In ORF112 Zalpha, the C-terminal exchange creates a
hinge region that flexibly connects the two monomers. The hinge
is formed by the residues of the wing where single or double pro-
line residues are a conserved feature of Z domains, raising the
possibility that similar domain swapping might be a widespread
strategy for dimer formation but has escaped detection until now.
Significantly, the exchanged residues include Trp274 (Trp195 in
ADAR1), a key residue for the interaction of the domain with
DNA, and thus the dimer creates a conserved DNA interaction
surface that is formed with the contribution of both monomers.
A possible role for phosphate groups in the induction of do-
main swapping. The electron density of the Zalpha ORF112 crys-
tals allowed us to clearly locate a number of sulfate ions bound to
the surface of the protein. That was not unexpected given the high
positive charge of the domain’s surface and the high concentra-
tion of sulfate ions present in the crystallization conditions (2 M
ammonium sulfate). Surprisingly, however, the superposition of
theORF112 Zalpha domains on ADAR1 Zalpha revealed a precise
positioning of sulfate ions at locations occupied by the backbone
DNA phosphates in the protein-DNA complex and in contact
with residues involved in domain swapping (Fig. 3B). This obser-
vation suggested that sulfate ions may have a role in inducing the
domain swapping phenomenon. To shed light on the mechanism
of the domain swapping, we used size exclusion chromatography
to characterize the oligomeric state of the protein under different
conditions. Interestingly, under our standard conditions (50 mM
Tris [pH 7.5], 100 mM KCl), the protein eluted as a single clear
peak corresponding to 7.67 kDa, close to the molecular mass ex-
pected for themonomeric form of the protein (Fig. 2E, panel 1). A
smaller second peak, roughly corresponding to the expected mo-
lecular mass of the dimer, appeared only when 50 mM ammo-
nium sulfate was introduced into the buffer, clearly confirming a
role of the sulfate ions in dimer formation (Fig. 2E, panel 2). A
third minor peak was also observed, probably corresponding to a
higher-order oligomerization of the protein. All peakswere shown
to contain a protein of identical molecular weight in SDS-PAGE,
suggesting that indeed they represent different oligomeric states of
the same protein (Fig. 2F, panel 2).
Domain swapping andDNAbinding.Wewere puzzled by the
results of the crystallization using a mixture of protein and DNA,
which consistently resulted in protein-only crystals, despite the
strong interaction ofORF112 ZalphawithDNA, as revealed by gel
shift experiments. Modeling of the DNA-bound form of ORF112
Zalpha, based on the structure of the complex of Zalpha ADAR1
with Z-DNA, showed that steric hindrance between the two
monomers comprising the dimer, now located at a fixed distance
from the binding site,might interferewithDNAbinding (Fig. 3B).
Nevertheless, we cannot exclude the possibility that the flexible
nature of the hinge regionmay allow a repositioning of the second
monomer in a way that permits the interaction of one of the
monomers with DNA. Whatever the explanation, our modeling
clearly suggests that the dimer of ORF112 Zalpha cannot recapit-
ulate the way two monomers of ADAR1 Zalpha interact with a
single (CG)3 binding site. If the dimeric form of ORF112 Zalpha
does not bind DNA, we hypothesized that the equilibrium be-
tween a monomeric form and a dimeric form might allow the
transition between a monomeric DNA binding-competent form
and an inactive ORF112 Zalpha dimer. Therefore, we performed
band shift experiments using the isolated oligomers from size ex-
clusion chromatography experiments. With the caveat that there
was some overlap between monomer and dimer peaks, signifi-
cantly reduced binding of DNA was observed for the dimer frac-
tion compared to the monomer (Fig. 2F, panel 1).
DISCUSSION
Here we describe a new member of the Zalpha domain family
found in a protein (ORF112) of cyprinid herpesvirus 3, a member
of the family Alloherpesviridae. This is an interesting finding as, to
date, no Zalpha domains have been found in any member of the
Herpesviridae, which infect mammals, birds, and reptiles. On the
other hand, Zalpha domains are a feature of the poxviral protein
E3L, which is present in all known poxviruses and which is crucial
for the subversion of the host interferon response. The E3L pro-
tein acts through the inhibition of PKR (11) and has also been
suggested to inhibit the action of DAI, a cytoplasmic sensor of
nucleic acids with two Zalpha domains. Finding a similar virus
evasion protein in Alloherpesviridae is consistent with previous
work which identified similarities between genes encoding thymi-
Tomé et al.
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dylate monophosphate kinase (TmpK), ribonucleotide reductase
and thymidine kinase in poxviruses and the family Alloherpesviri-
dae, suggesting that Alloherpesviridae may be evolutionarily re-
lated to poxviruses (14).
Fish of the cyprinid family, including zebrafish, were recently
shown to have, in addition to PKR, a protein called PKZ, with two
Z-DNA binding Zalpha domains replacing the dsRNA binding
domain. The PKZ protein inhibits cellular protein translation, as
does PKR, but in this case in response to DNA repeats which can
adopt a Z-DNA conformation (22). We show that the Zalpha
domain of ORF112 is homologous to PKZ Zalpha domains and it
can compete with Zalpha1 of PKZ in DNA binding in vitro.
These results suggest that the function of ORF112 may be to
block the activation of PKZ and the subsequent antiviral host
responses. The mechanism of such inhibition would be com-
petition between ORF112 and cellular receptors for nucleic
acids, as has been shown for E3L. Our structure also suggests
potential alternative models that involve inactive heterodimer
formation between host Zalpha and ORF112. Further work
could evaluate the formation of domain-swapped het-
erodimers with other members of the Zalpha family. Based on
the above results, and because CyHV3 is emerging as a source
FIG 3 Overview of the structure of theORF112 Zalpha domain. (A) Fourmonomers of ORF112 are present in the asymmetric unit. Themonomers formdimers
through domain swapping involving the last -strand of each domain and residues P269 to A278. The swapped -strand intercalates in the -sheet between
strands1 and2. The twodimers have different angles betweenmonomers at the hinge region, resulting in a different distance betweenmonomers. The distance
between C of Tyr257 residues of each dimer is shown as a reference. (B) Monomer A of ORF112 Zalpha (magenta) was superimposed on a Zalpha ADAR1
monomer (orange) from the crystal structure of the Zalpha-DNA complex (PDB, 1QBJ). Also shown are the ORF112 monomer B (yellow) and the second
monomer from the ADAR1 Zalpha structure (translucent orange). For clarity, only one DNA strand along with key DNA-interacting residues Tyr177/Tyr257,
Asn173/Asn253, and Trp 195/Trp274 (ADAR1/ORF112) are shown in stick representation. The location of a sulfate ion (S1) occupying the same location as a
critical Z-DNA recognition backbone phosphate and contacting the domain-swapping hinge region is indicated in blue.
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of devastating disease for carp and koi worldwide, ORF112may
represent an important pharmacological target.
Despite a relatively low sequence identity, structurally the Zal-
pha domain of ORF112 shares the fold of Zalpha domains from
ADAR1, DAI, and E3L. Moreover, key DNA-interacting residues
are conserved, as well as the major features of its hydrophobic
core, and consistent with this, ORF112 firmly binds oligonucleo-
tides bearing CpG repeats in vitro. At the same time, the crystal-
lographic structure of ORF112 Zalpha forms dimers through do-
main swapping of the C-terminal strand, a unique feature not
previously observed for Zalpha domains. The possible functional
significance of this observation is currently unknown. It is possible
that the dimer formation may have been induced by the crystalli-
zation conditions, as we did not detect these structures under
physiological conditions. Intriguingly, however, in the crystal
structure we found sulfate ions occupying positions that accu-
rately reflect the positions of DNA phosphates in the complex as
well as at key hinge positions of the swapped loops (Fig. 3B).
Indeed we show that sulfate binding is necessary for the induction
of domain swapping (Fig. 2E). This finding raises the possibility
that DNA binding may induce similar reorganization and oli-
gomerization of the protein, although it is unclear how the con-
formational changes could occur without disrupting the complex.
Indeed, oligomerization of Zalpha domain-containing pro-
teins on DNA has been previously suggested to play important
role in their function (23). Further work using the entire PKZ
kinase would be needed to clarify the interaction between
ORF112 and PKZ.
In conclusion, we have identified a new member of the Z do-
main family, a potential inhibitor of the interferon response in
cyprinid herpesvirus 3. This protein exhibits the novel character-
istic of domain swapping as a mechanism for its dimerization and
oligomerization.
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